These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 1589759)

  • 1. Malignant hyperthermia.
    MacLennan DH; Phillips MS
    Science; 1992 May; 256(5058):789-94. PubMed ID: 1589759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The genetic basis of malignant hyperthermia.
    MacLennan DH
    Trends Pharmacol Sci; 1992 Aug; 13(8):330-4. PubMed ID: 1329295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The genetic basis of malignant hyperthermia.
    Moochhala SM; Tan WT; Lee TL
    Ann Acad Med Singap; 1994 Jul; 23(4):475-8. PubMed ID: 7979121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a mutation in porcine ryanodine receptor associated with malignant hyperthermia.
    Fujii J; Otsu K; Zorzato F; de Leon S; Khanna VK; Weiler JE; O'Brien PJ; MacLennan DH
    Science; 1991 Jul; 253(5018):448-51. PubMed ID: 1862346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cosegregation of porcine malignant hyperthermia and a probable causal mutation in the skeletal muscle ryanodine receptor gene in backcross families.
    Otsu K; Khanna VK; Archibald AL; MacLennan DH
    Genomics; 1991 Nov; 11(3):744-50. PubMed ID: 1774073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ryanodine receptors and their role in genetic diseases (review).
    Leeb T; Brenig B
    Int J Mol Med; 1998 Sep; 2(3):293-300. PubMed ID: 9855701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the calcium release channel of skeletal muscle sarcoplasmic reticulum in malignant hyperthermia.
    MacLennan DH; Chen SR
    Ann N Y Acad Sci; 1993 Dec; 707():294-304. PubMed ID: 9137560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia.
    MacLennan DH; Duff C; Zorzato F; Fujii J; Phillips M; Korneluk RG; Frodis W; Britt BA; Worton RG
    Nature; 1990 Feb; 343(6258):559-61. PubMed ID: 1967823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and functional correlates of a mutation in the malignant hyperthermia-susceptible pig ryanodine receptor.
    Mickelson JR; Knudson CM; Kennedy CF; Yang DI; Litterer LA; Rempel WE; Campbell KP; Louis CF
    FEBS Lett; 1992 Apr; 301(1):49-52. PubMed ID: 1333412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ryanodine receptor type 1 (RyR1) possessing malignant hyperthermia mutation R615C exhibits heightened sensitivity to dysregulation by non-coplanar 2,2',3,5',6-pentachlorobiphenyl (PCB 95).
    Ta TA; Pessah IN
    Neurotoxicology; 2007 Jul; 28(4):770-9. PubMed ID: 17023049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biology of malignant hyperthermia: a disease of the calcium channels of the skeletal muscle].
    Monnier N; Lunardi J
    Ann Biol Clin (Paris); 2000; 58(2):147-56. PubMed ID: 10760701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant hyperthermia: a pharmacogenetic disease of Ca++ regulating proteins.
    Nelson TE
    Curr Mol Med; 2002 Jun; 2(4):347-69. PubMed ID: 12108947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refinement of diagnostic assays for a probable causal mutation for porcine and human malignant hyperthermia.
    Otsu K; Phillips MS; Khanna VK; de Leon S; MacLennan DH
    Genomics; 1992 Jul; 13(3):835-7. PubMed ID: 1639409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant hyperthermia and excitation-contraction coupling.
    Melzer W; Dietze B
    Acta Physiol Scand; 2001 Mar; 171(3):367-78. PubMed ID: 11412150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mutations in the gene responsible for malignant hyperthermia].
    Fujii J; Otsu K
    Seikagaku; 1992 Sep; 64(9):1129-33. PubMed ID: 1460346
    [No Abstract]   [Full Text] [Related]  

  • 16. Abnormal ryanodine receptor channels in malignant hyperthermia.
    Fill M; Coronado R; Mickelson JR; Vilven J; Ma JJ; Jacobson BA; Louis CF
    Biophys J; 1990 Mar; 57(3):471-5. PubMed ID: 2306496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics of malignant hyperthermia.
    Brandom BW
    ScientificWorldJournal; 2006 Dec; 6():1722-30. PubMed ID: 17195870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypes associated with malignant hyperthermia susceptibility in swine genotyped as homozygous or heterozygous for the ryanodine receptor mutation.
    Fletcher JE; Calvo PA; Rosenberg H
    Br J Anaesth; 1993 Sep; 71(3):410-7. PubMed ID: 8398525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for genetic heterogeneity of malignant hyperthermia susceptibility.
    Deufel T; Golla A; Iles D; Meindl A; Meitinger T; Schindelhauer D; DeVries A; Pongratz D; MacLennan DH; Johnson KJ
    Am J Hum Genet; 1992 Jun; 50(6):1151-61. PubMed ID: 1598899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Physiology and physiopathology of ryanodine receptors in swine. Significance of sensitivity to stress, stress myopathies, malignant hyperthermia and meat quality].
    Martens H
    Tierarztl Prax; 1997 Jan; 25(1):41-51. PubMed ID: 9157629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.